$BFLY

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong

Original reporting
Published Sep 15, 2026, 3:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 6:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$BFLY
Bullish
high confidence
Mentioned
$BFLY
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BFLYBullishMed
01

Why it matters

The disclosed $74M Midjourney deal and the platform roadmap provide fresh growth catalysts, shifting investor perception.

02

Market read

New partnership and strategic shift could drive BFLY stock higher and influence the broader med‑tech sector.

03

What to watch

Capital intensity of chip development and potential competition from larger imaging players could limit upside.

Relevance 7/10Novelty 7/10Timing: today

Background

Butterfly Network used the Morgan Stanley Global Healthcare Conference to reposition from handheld ultrasound to a broader imaging platform.

Company-level read

Ticker impact

$BFLYBullishHigh confidence
Context

Butterfly Network announced a new $74M five‑year Midjourney partnership and outlined a platform shift to chips, cloud and AI at the Morgan Stanley healthcare conference.

Expected impact

Potential short‑term price lift on news, with longer‑term upside if platform execution succeeds.

Evidence & confidence

A sizable multi‑year contract and clear strategic roadmap provide concrete growth catalysts.

Market effects

Highlights a trend of medical imaging firms moving toward semiconductor‑based platforms, pressuring traditional ultrasound vendors.

U.S. healthcare technology sector may see increased investor interest.

Partnership with Midjourney and TSMC underscores cross‑border tech collaborations.

Counterpoint

Execution risk remains high; platform rollout could be delayed, and partners may not generate expected recurring revenue.

Key entities

  • Butterfly Network

    Medical imaging device maker transitioning to a semiconductor‑based platform.

  • Midjourney

    AI company entering a five‑year licensing agreement worth at least $74M.

Related articles

$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.

$BFLYMedAI 9/10

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Butterfly Network (BFLY) reported Q2 2026 revenue of $32.6M, up 39% y/y, driven by Embedded revenue of $10.8M (+439%). Gross profit rose to $23.3M and gross margin to 71%. Adjusted EBITDA loss narrowed to $1.4M. Q3 revenue guidance is $26M to $30M, and FY2026 revenue guidance is $119M to $123M.

$BFLYMedAI 8/10

Butterfly Network, Inc. Q2 2026 Earnings Call Summary

Butterfly Network, Inc. reported Q2 2026 progress driven by POCUS, Home and Community Care, and Embedded partnerships. Embedded revenue rose 439% on the Midjourney partnership. Gross margin was 71%. Full-year 2026 revenue guidance was raised to $119 million-$123 million. Home and Community Care first commercial implementation starts Oct 1, with revenue in Q4 2026.

$BFLYMedAI 8/10

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Financial Officer - John Doherty Chairman and Chief Executive Officer - Joseph DeVivo TAKEAWAYS Revenue -- $32.6 million, an increase of 39% year over year driven primarily by the growth of the Butterfly Embedded segment. Embedded Revenue -- $10.8 million, representing 439% year-over-year growth due to development work and milestones from the Midjourney partnership.

$BFLYHighAI 9/10

Butterfly Network, Inc. (BFLY): Results of Operations and Financial Condition

Butterfly Network, Inc. (BFLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Butterfly Network Reports Second Quarter 2026 Financial Results Delivered Record Revenue and Adjusted EBITDA Loss Above Guidance • Raised full year Revenue and Improved Adjusted EBITDA Guidance • Delivered quarterly Revenue of $32.6 million in Q2, representing 39% Yo